Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation

ObjectiveAutoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTre...

Full description

Bibliographic Details
Main Authors: Fabienne Mazerolles, Marie-Claude Stolzenberg, Olivier Pelle, Capucine Picard, Benedicte Neven, Alain Fischer, Aude Magerus-Chatinet, Frederic Rieux-Laucat
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00718/full
id doaj-5d860a781cf64d7bb1b6f11dfc9c80a1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Fabienne Mazerolles
Fabienne Mazerolles
Marie-Claude Stolzenberg
Marie-Claude Stolzenberg
Olivier Pelle
Olivier Pelle
Capucine Picard
Capucine Picard
Capucine Picard
Capucine Picard
Benedicte Neven
Benedicte Neven
Benedicte Neven
Alain Fischer
Alain Fischer
Alain Fischer
Aude Magerus-Chatinet
Aude Magerus-Chatinet
Frederic Rieux-Laucat
Frederic Rieux-Laucat
spellingShingle Fabienne Mazerolles
Fabienne Mazerolles
Marie-Claude Stolzenberg
Marie-Claude Stolzenberg
Olivier Pelle
Olivier Pelle
Capucine Picard
Capucine Picard
Capucine Picard
Capucine Picard
Benedicte Neven
Benedicte Neven
Benedicte Neven
Alain Fischer
Alain Fischer
Alain Fischer
Aude Magerus-Chatinet
Aude Magerus-Chatinet
Frederic Rieux-Laucat
Frederic Rieux-Laucat
Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
Frontiers in Immunology
human
autoimmune lymphoproliferative syndrome-FAS
cell proliferation
regulatory T cell
suppression assay
author_facet Fabienne Mazerolles
Fabienne Mazerolles
Marie-Claude Stolzenberg
Marie-Claude Stolzenberg
Olivier Pelle
Olivier Pelle
Capucine Picard
Capucine Picard
Capucine Picard
Capucine Picard
Benedicte Neven
Benedicte Neven
Benedicte Neven
Alain Fischer
Alain Fischer
Alain Fischer
Aude Magerus-Chatinet
Aude Magerus-Chatinet
Frederic Rieux-Laucat
Frederic Rieux-Laucat
author_sort Fabienne Mazerolles
title Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
title_short Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
title_full Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
title_fullStr Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
title_full_unstemmed Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
title_sort autoimmune lymphoproliferative syndrome-fas patients have an abnormal regulatory t cell (treg) phenotype but display normal natural treg-suppressive function on t cell proliferation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-04-01
description ObjectiveAutoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS.ResultsThe proportion of CD25highCD127low Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3+CD4+ T cells from ALPS patients and thus an abnormally low proportion of CD25highFOXP3+ Helios+ T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3lowCD45RA+) and an unusual subpopulation (CD4+CD127lowCD15s+CD45RA+). Despite this abnormal phenotype, the CD25highCD127low Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression.ConclusionAn abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.
topic human
autoimmune lymphoproliferative syndrome-FAS
cell proliferation
regulatory T cell
suppression assay
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00718/full
work_keys_str_mv AT fabiennemazerolles autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT fabiennemazerolles autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT marieclaudestolzenberg autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT marieclaudestolzenberg autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT olivierpelle autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT olivierpelle autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT capucinepicard autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT capucinepicard autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT capucinepicard autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT capucinepicard autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT benedicteneven autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT benedicteneven autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT benedicteneven autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT alainfischer autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT alainfischer autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT alainfischer autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT audemageruschatinet autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT audemageruschatinet autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT fredericrieuxlaucat autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
AT fredericrieuxlaucat autoimmunelymphoproliferativesyndromefaspatientshaveanabnormalregulatorytcelltregphenotypebutdisplaynormalnaturaltregsuppressivefunctionontcellproliferation
_version_ 1725591876165173248
spelling doaj-5d860a781cf64d7bb1b6f11dfc9c80a12020-11-24T23:15:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-04-01910.3389/fimmu.2018.00718308775Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell ProliferationFabienne Mazerolles0Fabienne Mazerolles1Marie-Claude Stolzenberg2Marie-Claude Stolzenberg3Olivier Pelle4Olivier Pelle5Capucine Picard6Capucine Picard7Capucine Picard8Capucine Picard9Benedicte Neven10Benedicte Neven11Benedicte Neven12Alain Fischer13Alain Fischer14Alain Fischer15Aude Magerus-Chatinet16Aude Magerus-Chatinet17Frederic Rieux-Laucat18Frederic Rieux-Laucat19INSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FranceINSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FranceINSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceINSERM UMR1163, Cell Sorting Facility, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FrancePaediatric Haematology-Immunology and Rheumatology Unit, Necker-Enfants Malades Hospital, Assistance Publique—Hôpitaux de Paris (APHP), Paris, FranceCenter for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, APHP, Paris, FranceLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, FranceINSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FrancePaediatric Haematology-Immunology and Rheumatology Unit, Necker-Enfants Malades Hospital, Assistance Publique—Hôpitaux de Paris (APHP), Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FrancePaediatric Haematology-Immunology and Rheumatology Unit, Necker-Enfants Malades Hospital, Assistance Publique—Hôpitaux de Paris (APHP), Paris, FranceCollège de France, Paris, FranceINSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FranceINSERM UMR1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Paris, FranceParis Descartes—Sorbonne Paris Cité University, Imagine Institute Paris, Paris, FranceObjectiveAutoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS.ResultsThe proportion of CD25highCD127low Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3+CD4+ T cells from ALPS patients and thus an abnormally low proportion of CD25highFOXP3+ Helios+ T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3lowCD45RA+) and an unusual subpopulation (CD4+CD127lowCD15s+CD45RA+). Despite this abnormal phenotype, the CD25highCD127low Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression.ConclusionAn abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00718/fullhumanautoimmune lymphoproliferative syndrome-FAScell proliferationregulatory T cellsuppression assay